Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Chris Rinsch | M | - |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | 17 Jahre |
Christian Fuessinger | M | 51 |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | 9 Jahre |
Johannes Suter | M | - |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | 9 Jahre |
Georgette Schmid | F | - |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | 4 Jahre |
Pierre Landolt | M | 77 |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | 17 Jahre |
Patrick Aebischer | M | 70 |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | 17 Jahre |
Brian Ray | M | - |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | 1 Jahre |
Wilhelm Kurt Leimer | M | 66 |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | - |
Odile Rundquist | M | - |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | 7 Jahre |
Andreas G. Schmid | M | 67 |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | 7 Jahre |
Nadya Steiner | F | - |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | 9 Jahre |
Thierry Lombard | M | - |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | - |
Franz Albers | M | - |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | - |
Toni Neuhaus | M | - |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | - |
Philipp Berner | M | - |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | 4 Jahre |
Simon Hauswirth | M | - |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | 4 Jahre |
Philipp Albers | M | - |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | 8 Jahre |
Philipp Bucher | M | - |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | 6 Jahre |
Silvio Tarchini | M | - |
Helvetica Capital AG
Helvetica Capital AG Investment ManagersFinance Helvetica Capital AG is an independent private equity/venture capital firm headquartered in Zurich, Switzerland. The firm was founded in August 2015 by Johannes Suter. | - |
Grégory Behar | M | 55 |
Amazentis SA
Amazentis SA Miscellaneous Commercial ServicesCommercial Services Amazentis SA is a Swiss innovative life science company that focuses on developing products targeting mitochondrial health for advanced nutrition. The company was founded in 2007 by Pierre Landolt, Patrick Aebischer, and Chris Rinsch, and it is currently based in Lausanne, Switzerland. The company has published its research on Mitopure™ Urolithin A in top peer-reviewed scientific journals, including Nature Medicine, Nature Metabolism, JAMA Network Open, and European Journal of Clinical Nutrition. Amazentis has a strategic partnership with Nestlé Health Science to expand the health applications of Mitopure™. Brian Ray has been the CEO of the company since 2023. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Schweiz | 20 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Eric Lohrer
- Persönliches Netzwerk